Synchronous Malignancies: Pathological Analysis of Three Patients, Each with Dual Malignancies
暂无分享,去创建一个
R. Lal | P. Chatterjee | R. Biswas | Rakesh Kumar | M. Osama | Gunjan Saini
[1] Jiafeng Gao,et al. Tumor-associated macrophages in tumor progression and the role of traditional Chinese medicine in regulating TAMs to enhance antitumor effects , 2022, Frontiers in Immunology.
[2] Wen-Chi Chen,et al. Synchronous/Metachronous Multiple Primary Malignancies: Review of Associated Risk Factors , 2022, Diagnostics.
[3] F. Couch,et al. Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary Cancers. , 2020, JCO precision oncology.
[4] H. Pan,et al. Multiple Primary Malignant Tumors - A Clinical Analysis of 15,321 Patients with Malignancies at a Single Center in China , 2018, Journal of Cancer.
[5] Sitao Wu,et al. Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing , 2019, JAMA Oncology.
[6] P. McLoone,et al. Second primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study , 2014, BMC Cancer.
[7] N. Rosen,et al. Induction of cutaneous squamous cell carcinomas by RAF inhibitors: cause for concern? , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] D. Rubin,et al. Association between colorectal cancer and urologic cancers. , 2008, Archives of internal medicine.
[9] S. Warren. Multiple primary malignant tumors. A survey of the literature and a statistical study , 1932 .